rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

PMV Pharmaceuticals, Inc.

PMVP · Nasdaq

Health CareBiotechnologyAbove a falling average

PMVP stood above a rising 150-day average in 16 of the last 52 weekly readings, and has been out of that trend for the last 2 weeks. It is 3.7% above that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−12 points in four weeks); Health Care: 28% (−6 points in four weeks).

Statistics

Rotation
Above a falling average
Weeks in an uptrend
out for 2
Industry in uptrend
18% -12 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$1.5M
Officials’ trades on record
0
Institutions holding
61 (-3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 16 of 52 weeks.

22 Apr – 21 Oct
16%27%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1.5M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months1
Buyers · sellers0 · 1

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders61-3 on the quarter
New · exited4 · 7
Reported value$42.9M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BML Capital Management, LLCadded · filed 7 Aug 20265,330,000$7.1M+10,000+0.2%
TANG CAPITAL MANAGEMENT LLCunchanged · filed 14 Aug 20264,245,085$5.7M00.0%
Sio Capital Management, LLCreduced · filed 14 Aug 20262,634,137$3.5M-442,443−14.4%
Euclidean Capital LLCunchanged · filed 14 Aug 20262,627,643$3.5M00.0%
ADAGE CAPITAL PARTNERS GP, L.L.C.added · filed 14 Aug 20262,360,000$3.2M+500,000+26.9%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20262,012,020$2.7M+37,114+1.9%
ArrowMark Colorado Holdings LLCreduced · filed 13 Aug 20261,959,579$2.6M-913,185−31.8%
TWO SIGMA INVESTMENTS, LPadded · filed 14 Aug 20261,954,136$2.6M+69,606+3.7%
Eversept Partners, LPreduced · filed 14 Aug 20261,890,904$2.5M-457,456−19.5%
BlackRock, Inc.added · filed 7 Aug 2026919,818$1.2M+45,444+5.2%
31 Mar 2023 – 30 Jun 2026
527393Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Matthew Joseph Eckler Company insiderDirector · last 1 Oct 20260 · 0
Arnold J. Levine Company insiderDirector · last 4 Jun 20260 · 5
Carol Giltner Gallagher Company insiderDirector · last 4 Jun 20260 · 0
Charles M. Baum Company insiderDirector · last 4 Jun 20260 · 0
Kirsten Flowers Company insiderDirector · last 4 Jun 20260 · 0
Laurie Stelzer Company insiderDirector · last 4 Jun 20260 · 0
David Henry Mack Company insiderPresident and CEO · last 5 Mar 20260 · 6
Deepika Jalota Company insiderChief Development Officer · last 5 Mar 20260 · 4
Michael Carulli Company insiderChief Financial Officer · last 5 Mar 20260 · 2
Robert Ticktin Company insiderGeneral Counsel & COO · last 5 Mar 20260 · 1
Orbimed Capital Gp V Llc Company insider10% owner · last 23 Oct 20250 · 2
ORBIMED ADVISORS LLC Company insider10% owner · last 10 Sep 20251 · 1

Same industry

MRNA ModernaLeading+168%
ENTX Entera BioLeading+53%
XNCR XencorLeading+41%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-82.0%
Interest coverFY 2025 · to 31 Dec 2025-13.60×
Share count trendFY 2025 · to 3 Mar 2026-0.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$38.0M
Free cash flowFY 2025 · to 31 Dec 2025−$73.6M

Analyst forecasts

No analyst forecasts yet.